Burosumab for CSHS

Clinical trial NCT03993821 · COMPLETED

Trial details

NCT number: NCT03993821
Sponsor: Laura Tosi
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)Epidermal Nevus Syndrome

Start date: 2019-07-01
Primary completion: 2022-10-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.